2David L, Koichi H, Sergio D, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoitic precursor cells blocks tumor angiogenesis and growth [J]. Nature Med,2001,7( 11 ): 1194-1201.
3Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis [J]. Immunity, 1995,3(6):673-682.
4Baetu TM, Hiscott J. On the TRAIL to apoptosis [J]. Cytokine Growth Factor Rev, 2002,13(3): 199-207.
5Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis [J]. Science,1997,275 (14): 964-967.
6Davidoff AM, Catherine YCN, Brown P, et al. Bone marrowderived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice [J]. Clin Cancer Res, 2001,7(9):2870-2879.
7Peter V, Sabine B, Mathias L, et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis [J]. J Exp Med, 2003,197(12): 1755-1765.
5Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induce apoptosis.Immunity,1995,3(6):673.
6]Fisher MJ,Virmani AK,Wu L,et al.Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head neck cancer.Clin Cancer Res,2001,7:1688.
7Chen X,Kandasamy K,Srivastava P K.Differential roles of RelA and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis inducing ligand signaling.Cancer Res,2003,63:1059.
8Arts HJ,de Jong S,Hollema H,et al.Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma.Gynecol Oncol,2004,92(3):794.
9Tomek S,Horak P,Pribill I,et al.Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.Gynecol Oncol,2004,94(1):107.
10Vignati S,Codegoni A,Polato E,et al.Trail activity in human ovarian cancer cells:potentiation of the action of cytotoxic drugs.Eur J Cancer,2002,38(1):177.
